Effects of Traditional Chinese Medicine on Bronchiectasis Patients

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the effectiveness of Traditional Chinese Medicine (TCM) on patients with clinically stable bronchiectasis by a multi-center, randomized, double-blind, controlled trial: one, TCM treatments based on syndrome differentiation; the other, a placebo of TCM treatment.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Henan University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• A confirmed diagnosis of clinically stable bronchiectasis

• Age between 18 and 80 years

• Syndrome differentiation meets criteria of syndrome of Qi deficiency of lung and phlegm-turbidity obstructing the lung, syndrome of Qi and Yin deficiency of the lung and the phlegm-heat obstructing the lung

• Without participations in other interventional trials in the previous one month

• With the informed consent signed

Exclusion Criteria:

• Current respiratory disorders other than bronchiectasis (e.g. COPD,bronchial asthma, lung cancer,active tuberculosis, Interstitial lung disease, pulmonary thromboembolic, or Other patients who have an impact on the observation of disease)

• Patients with severe cardiovascular disease (e.g. Acute myocardial infarction,Acute heart failure)

• Severe liver disease(e.g.Active phase of hepatitis, Cirrhosis, Severe impairment of liver function by portal hypertension)

• Severe renal disease(e.g. renal transplant, dialysis)

• Patients with large hemoptysis in the last month

• Pregnant and lactating women

• Insanity, Dementia, and all kinds of Psychosis

• Smoking patients (Years of smoking10/ package year)

• Participating in other clinical trials with other interventions;

• Allergic to the used medicine.